Main diagnosis (ICD-10) | Indicator | Period/Comparison | São Paulo | Rio de Janeiro | Manaus | Fortaleza | Recife | BrasÃlia |
---|---|---|---|---|---|---|---|---|
Contraceptive (Z30) | Hospitalizations/ fortnight Mean (sd) | Before | 462.7 (83.0) | 99.4 (13.8) | 23.0 (8.6) | 31.3 (7.5) | 121.6 (21.2) | 50.7 (11.6) |
Pandemic | 114.6 (117.3) | 59.1 (22.8) | 15.4 (11.7) | 23.4 (6.5) | 54.0 (28.5) | 29.4 (15.6) | ||
T-Test (p-value) | < 0.0001 | < 0.0001 | 0.0259 | 0.0017 | < 0.0001 | < 0.0001 | ||
Mortality (%) | Before | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | |
Pandemic | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
Fisher’s Exact Test (p-value) | 1.0000 | – | – | 1.0000 | – | – | ||
Septicemia (A40, A41) | Hospitalizations/ fortnight Mean (sd) | Before | 408.5 (29.1) | 147.8 (22.2) | 50.7 (9.1) | 70.2 (9.2) | 94.0 (16.7) | 64.8 (10.9) |
Pandemic | 306.1 (55.4) | 107.1 (24.4) | 37.1 (18.7) | 54.6 (20.6) | 59.5 (12.2) | 55.3 (14.2) | ||
T-Test (p-value) | < 0.0001 | < 0.0001 | 0.0205 | 0.0161 | < 0.0001 | 0.0223 | ||
Mortality (%) | Before | 59.2 | 75.7 | 69.1 | 62.1 | 56.3 | 36.2 | |
Pandemic | 61.7 | 76.4 | 71.5 | 58.0 | 51.3 | 26.1 | ||
Fisher’s Exact Test (p-value) | 0.0045 | 0.6183 | 0.3377 | 0.0521 | 0.0124 | < 0.0001 | ||
Cholelithiasis (K80) and Cholecystitis (K81) | Hospitalizations/ fortnight Mean (sd) | Before | 538.7 (48.4) | 206.8 (30.7) | 171.2 (18.2) | 151.3 (16.9) | 191.9 (24.2) | 158.9 (21.9) |
Pandemic | 238.1 (121.9) | 104.2 (47.1) | 95.4 (45.9) | 79.5 (46.2) | 104.8 (54.6) | 117.9 (27.2) | ||
T-Test (p-value) | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 | ||
Mortality (%) | Before | 0.6 | 1.0 | 0.9 | 0.8 | 1.1 | 0.4 | |
Pandemic | 1.1 | 1.8 | 1.1 | 1.4 | 1.6 | 0.4 | ||
Fisher’s Exact Test (p-value) | 0.0046 | 0.0112 | 0.6267 | 0.0477 | 0.1336 | 0.8132 | ||
Acute myocardial infarction (I21) | Hospitalizations/ fortnight Mean (sd) | Before | 429.0 (51.2) | 130.1 (19.4) | 53.0 (9.0) | 82.4 (19.1) | 117.4 (21.5) | 90.4 (15.1) |
Pandemic | 369.2 (58.6) | 106.8 (19.2) | 40.3 (11.8) | 76.0 (24.9) | 106.9 (25.2) | 89.7 (12.8) | ||
T-Test (p-value) | 0.0018 | 0.0008 | 0.0005 | 0.3715 | 0.1717 | 0.8888 | ||
Mortality (%) | Before | 8.6 | 10.1 | 10.0 | 12.0 | 8.9 | 2.9 | |
Pandemic | 9.5 | 9.4 | 12.8 | 11.8 | 9.0 | 3.8 | ||
Fisher’s Exact Test (p-value) | 0.0663 | 0.4992 | 0.0772 | 0.8623 | 1.0000 | 0.1352 | ||
Heart failure (I50) | Hospitalizations/ fortnight Mean (sd) | Before | 357.6 (37.6) | 95.6 (16.2) | 84.0 (13.7) | 140.5 (14.9) | 183.0 (18.5) | 90.3 (15.8) |
Pandemic | 273.1 (52.0) | 71.9 (24.7) | 57.2 (21.5) | 85.6 (30.3) | 137.4 (44.4) | 64.6 (11.1) | ||
T-Test (p-value) | < 0.0001 | 0.0008 | 0.0005 | < 0.0001 | 0.0022 | < 0.0001 | ||
Mortality (%) | Before | 15.5 | 20.3 | 17.9 | 11.2 | 9.6 | 7.8 | |
Pandemic | 18.2 | 24.3 | 21.0 | 14.8 | 12.1 | 8.6 | ||
Fisher’s Exact Test (p-value) | 0.0002 | 0.0095 | 0.0640 | 0.0011 | 0.0029 | 0.4274 | ||
Stroke (I60-I64) | Hospitalizations/ fortnight Mean (sd) | Before | 434.2 (24.5) | 187.0 (20.3) | 45.3 (11.5) | 170.9 (22.6) | 349.2 (24.3) | 99.7 (12.5) |
Pandemic | 385.8 (36.5) | 193.3 (30.9) | 40.4 (13.8) | 133.3 (24.8) | 251.9 (43.3) | 97.4 (11.1) | ||
T-Test (p-value) | < 0.0001 | 0.4456 | 0.2305 | < 0.0001 | < 0.0001 | 0.5622 | ||
Mortality (%) | Before | 15.0 | 23.1 | 21.5 | 12.4 | 17.6 | 9.8 | |
Pandemic | 17.7 | 27.3 | 21.2 | 16.9 | 18.6 | 11.3 | ||
Fisher’s Exact Test (p-value) | < 0.0001 | < 0.0001 | 0.9503 | < 0.0001 | 0.1619 | 0.1526 | ||
Breast cancer (C50) | Hospitalizations/ fortnight Mean (sd) | Before | 295.1 (37.4) | 200.1 (17.8) | 17.8 (4.1) | 69.2 (13.4) | 152.5 (22.0) | 42.2 (5.4) |
Pandemic | 237.9 (39.8) | 161.3 (24.4) | 15.2 (3.9) | 58.5 (11.7) | 164.5 (16.8) | 41.6 (6.4) | ||
T-Test (p-value) | < 0.0001 | < 0.0001 | 0.0625 | 0.0167 | 0.0821 | 0.7461 | ||
Mortality (%) | Before | 8.0 | 12.8 | 11.3 | 3.0 | 7.9 | 9.4 | |
Pandemic | 9.0 | 14.2 | 14.6 | 2.8 | 4.7 | 7.7 | ||
Fisher’s Exact Test (p-value) | 0.0902 | 0.1094 | 0.2563 | 0.9008 | < 0.0001 | 0.2783 | ||
Pneumonia (J12-J18) | Hospitalizations/ fortnight Mean (sd) | Before | 550.8 (75.7) | 161.0 (23.4) | 88.7 (16.2) | 134.7 (26.7) | 142.7 (18.7) | 139.0 (29.2) |
Pandemic | 637.9 (149.3) | 277.6 (87.3) | 68.6 (28.4) | 80.8 (44.1) | 83.5 (33.0) | 136.8 (25.7) | ||
T-Test (p-value) | 0.0570 | 0.0002 | 0.0254 | 0.0005 | < 0.0001 | 0.8163 | ||
Mortality (%) | Before | 19.7 | 29.7 | 21.0 | 22.8 | 13.1 | 11.8 | |
Pandemic | 19.1 | 38.1 | 30.0 | 28.5 | 21.1 | 11.3 | ||
Fisher’s Exact Test (p-value) | 0.2834 | < 0.0001 | < 0.0001 | 0.0001 | < 0.0001 | 0.5966 | ||
Leg (S82), femur (S72), and forearm (S52) fractures | Hospitalizations/ fortnight Mean (sd) | Before | 661.3 (35.3) | 338.3 (21.3) | 92.3 (12.9) | 244.8 (26.1) | 177.0 (16.0) | 145.8 (9.4) |
Pandemic | 582.7 (82.4) | 335.4 (30.2) | 84.4 (26.1) | 223.0 (29.8) | 160.4 (30.2) | 152.3 (17.8) | ||
T-Test (p-value) | 0.0037 | 0.7244 | 0.2969 | 0.0216 | 0.0724 | 0.2187 | ||
Mortality (%) | Before | 1.5 | 2.2 | 1.0 | 0.6 | 1.1 | 0.4 | |
Pandemic | 1.7 | 3.2 | 2.0 | 0.9 | 1.2 | 0.3 | ||
Fisher’s Exact Test (p-value) | 0.1397 | 0.0003 | 0.0275 | 0.0817 | 0.7144 | 0.8252 | ||
Diabetes mellitus (E10-E14) | Hospitalizations/ fortnight Mean (sd) | Before | 170.1 (12.0) | 81.8 (10.1) | 73.8 (12.3) | 37.0 (7.4) | 65.1 (15.0) | 64.3 (8.5) |
Pandemic | 131.2 (28.8) | 69.2 (17.9) | 53.4 (18.3) | 36.8 (9.5) | 45.2 (11.5) | 48.1 (8.6) | ||
T-Test (p-value) | 0.0002 | 0.0267 | 0.0001 | 0.9372 | 0.0001 | < 0.0001 | ||
Mortality (%) | Before | 4.5 | 8.1 | 4.8 | 5.5 | 3.4 | 2.4 | |
Pandemic | 6.0 | 12.5 | 9.0 | 6.4 | 5.9 | 1.9 | ||
Fisher’s Exact Test (p-value) | 0.0101 | 0.0002 | < 0.0001 | 0.4859 | 0.0090 | 0.5428 |